Close Asset Management Ltd
- SEC CIK
- 0001718570
- Latest filing
- Aug 11, 2026
CLDX holding history
Celldex Therapeutics, Inc. in every 13F filed by Close Asset Management Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −133−100.0% | Sold out | Holders |
| Q2 2025 | 133 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 133 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 133 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 133 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 133 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 133 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 133 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 133 | $4.00K | <0.1% | +133 | New | Holders |